Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects

Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NT-proBNP Chemiluminescence Immunoassay: Implications for the Prediction of Symptomatic and Asymptomatic Structural Heart Disease

Thomas Mueller, Alfons Gegenhuber, Werner Poelz et al. · Clinical Chemistry · 2003 · 359 citations · Full text

Life Sciences, Cardiology, Biopharmaceutics +9

Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases

Toshihiro Tsuruda, Guido Boerrigter, Brenda K. Huntley et al. · Circulation Research · 2002 · 303 citations

Life Sciences, Molecular Biology, Physiology +16

Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure

Guillaume Lecoq, Christophe Leclercq, Emmanuelle Leray et al. · European Heart Journal · 2005 · 244 citations · Full text

Medicine, Cardiology, Electrophysiology +11

Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression

V. О. Polyakova, Stefan Hein, Sawa Kostin et al. · Journal of the American College of Cardiology · 2004 · 194 citations

Medicine, Cardiology, Molecular Medicine +13

Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction

Angelika Hammerer‐Lercher, Elke Neubauer, Silvana Müller et al. · Clinica Chimica Acta · 2001 · 189 citations

Medicine, Cardiology, Neurology +9